top of page

New drug screening method answers why Alzheimer’s drugs fail, suggests new targets







A new study sheds light on why Alzheimer's drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer's disease.


By analyzing disease mechanisms in human neurons, researchers led by the University of California San Diego developed a new method to screen drugs for treating Alzheimer's disease. Their work sheds light on why Alzheimer's drugs so far have been ineffective at curing or reversing the disease and identifies new targets for drug development.


Drug development for Alzheimer's has long been driven by the hypothesis that amyloid plaques -- formed by the buildup of amyloid-beta proteins in the brain -- are what kill neurons and cause Alzheimer's. As a result, many research efforts have focused on designing drugs that clear out these plaques.




43 views2 comments

2 Comments


King Fisher
King Fisher
Dec 22, 2023

buy Ritalin online in usa Ritalin, also known by its generic name methylphenidate, is a central nervous system stimulant commonly prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. As a medication, Ritalin primarily works by increasing the levels of neurotransmitters, such as dopamine and norepinephrine, in the brain. This heightened neurotransmitter activity aids in improving attention, focus, and impulse control, mitigating the core symptoms of ADHD. Typically available in immediate-release and extended-release forms, Ritalin provides flexibility in tailoring treatment to an individual's specific needs. The immediate-release formulation acts quickly, offering symptom relief for shorter durations, while the extended-release version provides a more sustained effect, often lasting throughout the school or work day. While Ritalin is considered effective for…

Like

bottom of page